Valuation: PuraPharm Corporation Limited

Market Cap 150M 19.11M 16.38M 15.35M 14.02M 26.45M 1.82B 26.72M 181M 70.47M 919M 71.76M 70.2M 3.04B P/E 2024
-6.13x
P/E 2025 -4.22x
Enterprise Value 465M 59.33M 50.84M 47.64M 43.51M 82.12M 5.66B 82.93M 562M 219M 2.85B 223M 218M 9.45B EV / Sales 2024
1.42x
EV / Sales 2025 1.5x
Free-Float
34.74%
Yield 2024 *
-
Yield 2025 -
1 month-1.75%
3 months-5.08%
6 months-16.42%
Current year-21.13%
1 week 0.28
Extreme 0.275
0.28
1 month 0.27
Extreme 0.27
0.31
Current year 0.27
Extreme 0.27
0.38
1 year 0.27
Extreme 0.27
0.46
3 years 0.27
Extreme 0.27
1.26
5 years 0.27
Extreme 0.27
2
10 years 0.27
Extreme 0.27
4.39
Manager TitleAgeSince
Chief Executive Officer 65 1998-05-04
Director of Finance/CFO 38 2023-12-31
Investor Relations Contact - -
Director TitleAgeSince
Chairman 65 1998-05-04
Director/Board Member 60 2011-12-01
Director/Board Member 72 2015-06-11
Date Insider Type Main position Quantity % Market Cap.
7/27/22 Other

Chief Executive Officer

30,000 0.0076%
7/27/22 Other 30,000 0.0076%
5/3/22 Other

Chief Executive Officer

77,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-39.78%-68.54% 19.11M
+0.98%-0.84%+21.57%+37.86% 17.81B
-1.38%+0.19%+12.48%+78.71% 13.41B
+0.85%-0.48%-0.65%+73.10% 11.85B
+2.04%-0.70%-38.11%-51.09% 11.73B
+0.89%-1.36%+5.46%+83.49% 10.35B
+4.22%+6.74% - - 10.52B
-0.51%+1.55%-5.74%-29.01% 9.56B
+3.44%+7.11%-7.51% - 7.93B
-0.77%-1.96%+15.24%-11.32% 7.3B
Average +0.98%+0.41%-4.12%+14.15% 10.05B
Weighted average by Cap. +1.03%+0.48%+1.66%+30.46%

Financials

2024 2025
Net sales 382M 48.74M 41.77M 39.14M 35.75M 67.47M 4.65B 68.14M 462M 180M 2.34B 183M 179M 7.76B 336M 42.88M 36.74M 34.43M 31.45M 59.35M 4.09B 59.94M 406M 158M 2.06B 161M 157M 6.83B
Net income -35.44M -4.52M -3.87M -3.63M -3.32M -6.26M -431M -6.32M -42.82M -16.67M -217M -16.98M -16.61M -720M -35.22M -4.49M -3.85M -3.61M -3.3M -6.22M -428M -6.28M -42.56M -16.57M -216M -16.87M -16.5M -716M
Net Debt 327M 41.7M 35.73M 33.48M 30.58M 57.72M 3.98B 58.29M 395M 154M 2.01B 157M 153M 6.64B 315M 40.22M 34.46M 32.29M 29.5M 55.67M 3.83B 56.22M 381M 148M 1.93B 151M 148M 6.41B
Logo PuraPharm Corporation Limited
PuraPharm Corporation Ltd is an investment holding company principally engaged in the concentrated Chinese medicine granule (CCMG) businesses. The Company operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces.
Employees
441
Date Price Change Volume
26-08-26 HK$0.2800 0.00% 51,000
26-08-25 HK$0.2800 0.00% 66,000
26-08-24 HK$0.2800 0.00% 0
26-08-21 HK$0.2800 0.00% 0
26-08-20 HK$0.2800 0.00% 76,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1498 Stock